This chemical has been de-listed or was not found. It may have been assessed and listed confidentially. Check Useful links 'AICIS assessment' and 'AICIS Google search' above. As a last resort contact AICIS directly and ask. If not listed, it must be categorised.

DISCLAIMER: Downloaded AIIC Inventory records searched were supplied by AICIS and incorporate all updates since published by AICIS according to the Act.

AICIS's own disclaimer includes these words ... '[Downloaded records] should not be relied on for the latest information about a chemical – you must search the online Inventory to see if your chemical is listed and what any terms of its listing are.'

It is reasonably expected that the person named in the Chemical information holder field above will provide the AICIS Executive Director with requested information for this chemical on the basis of our signed Memorandum of Understanding / notes of our phone discussions / minutes of our meetings / email correspondence and further as follows:

(Please strike out and/or adjust or amplify as necessary)

Information that demonstrates that the chemical has a solubility in water that is >5 g/L, measured following an acceptable test guideline for water solubility

OECD Test 105: Water Solubility

(OPPTS 830.7840)

Information on aquatic toxicity for all three trophic levels (fish, invertebrates and algae) from suitable in silico predictions on the chemical or in vivo studies on the chemical or from suitable read across information, conducted following acceptable test guidelines for aquatic toxicity, with the following results for all three trophic levels:

- acute aquatic toxicity >10 mg/L (96 h LC50 (fish), or 48 h EC50 (invertebrates) or 72 or 96 h ErC50 (algae)), or

- chronic aquatic toxicity NOEC or EC10 >1 mg/L (for chemicals that are not readily biodegradable), or

information that demonstrates that the chemical is a substance covered by Entry 9 of Annex V of the REACH Regulation

OECD Test 201: Freshwater Alga and Cyanobacteria, Growth Inhibition Test

(EU Annex V test methods C.3; OCSPP 850.4550; OPPT 797.1050; OPP 122-2; OPP 123-2)

OECD Test 202: Daphnia sp. Acute Immobilisation Test

(ISO 6341; EU Annex V test method C. 2; OCSPP 850.1010; OPP 72-2)

OECD Test 203: Fish, Acute Toxicity Test

(ISO 10229; EU Annex V test method C.1; OCSPP 850.1075; OPP 72-1; OPP 72-3)

OECD Test 210: Fish, Early-life Stage Toxicity Test

(OCSPP 850.1400; EU Annex V test method C.15)

OECD Test 211: Daphnia magna Reproduction Test

(OCSPP 850.1300; EU Annex V test method C.20)

Information that demonstrates the absence of mutagenic or genotoxic effects from both:

- information on the chemical or from suitable read across information that addresses gene mutations - this could be:

* a suitable in silico prediction, both with and without metabolic activation, or

* test results from a study conducted following an acceptable test guideline for gene mutations; and

- test results from a study on the chemical or from suitable read across information conducted following an acceptable test guideline for chromosomal abnormalities.

OECD Test 471: Bacterial Reverse Mutation Test

(EU Annex V test methods B.13 and B.14; OCSPP 870.5100; OPPT 798.5100; OPPT 798.5265; OPP 84-2)

OECD Test 473: In Vitro Mammalian Chromosomal Aberration Test

(EU Annex V test method B.10; OCSPP 870.5375; OPPT 798.5375; OPP 84-2)

OECD Test 474: Mammalian Erythrocyte Micronucleus Test

(EU Annex V test method B.12; OCSPP 870.5395; OPPT 798.5395; OPP 84-2)

OECD Test 475: Mammalian Bone Marrow Chromosomal Aberration Test

(EU Annex V test method B.11; OCSPP 870.5385; OPPT 798.5385; OPP 84-2)

OECD Test 476: In Vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes

(EU Annex V test method B.17; OCSPP 870.5300; OPPT 798.5300; OPP 84-2)

OECD Test 478: Rodent Dominant Lethal Test

(EU Annex V test method B.22; OPPT 798.5450, 870.5450)

OECD Test 485: Genetic toxicology, Mouse Heritable Translocation Assay

(EU Annex V test method B.25; OPPT 798.5460, 870.5460)

OECD Test 486: Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo

(EU Annex V test method B.39)

OECD Test 487: In Vitro Mammalian Cell Micronucleus Test

(EU Annex V test method B.49)

OECD Test 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays

(EU Annex V test method B.58)

OECD Test 489: In Vivo Mammalian Alkaline Comet Assay

OECD Test 490: In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene

A suitable in silico prediction indicating that the chemical is not irritating to skin or has no alerting groups for skin irritation

A suitable in silico prediction indicating that the chemical is not irritating to the eye

Suitable in silico prediction indicating that the chemical and its metabolites (if any) do not cause skin sensitisation; and

results from an in vitro study on the chemical or from suitable read across information, conducted following an acceptable test guideline for the 2nd key event in skin sensitisation, with a nonsensitising prediction; and

test results from an in vitro study on the chemical or from suitable read across information, conducted following an acceptable test guideline for the 3rd key event in skin sensitisation, with a non-sensitising prediction

OECD Test 406: Skin Sensitisation

(EU Annex V test method B.6; OCSPP 870.2600; OPPT 798.4100; OPP 81-6)

OECD Test 429: Skin Sensitisation

(EU Annex V test method B.42)

OECD Test 442A: Skin Sensitization

(EU Annex V test method B.50)

OECD Test 442B: Skin Sensitization

(EU Annex V test method B.51)

OECD Test 442C: In Chemico Skin Sensitisation

(EU Annex V test methods B.59; EURL ECVAM DB-ALM protocol No.154)

OECD Test 442D: In Vitro Skin Sensitisation

(EU Annex V test method B.60; EURL ECVAM DB-ALM protocol No.155)

OECD Test 442E: In Vitro Skin Sensitisation

(EURL ECVAM DB-ALM protocol No.158)

Suitable in silico prediction for acute toxicity (LD50) of the chemical of >2,000 mg/kg bw/day; and

test results from an in vitro study on the chemical or from suitable read across information for acute toxicity (LD50), conducted following an acceptable test guideline for acute oral toxicity, of >300 mg/kg bw

OECD Test 401: Acute Oral Toxicity

(EU Annex V test methods B.1, B.1 bis, B.1 tris; OCSPP 870.1100; OPPT 798.1175; OPP 81-1)

OECD Test 420: Acute Oral Toxicity - Fixed Dose Procedure

(EU Annex V test methods B.1, B.1 bis, B.1 tris; OCSPP 870.1100; OPPT 798.1175; OPP 81-1)

OECD Test 423: Acute Oral toxicity - Acute Toxic Class Method

(EU Annex V test methods B.1, B.1 bis, B.1 tris; OCSPP 870.1100; OPPT 798.1175; OPP 81-1)

OECD Test 425: Acute Oral Toxicity: Up-and-Down Procedure

(EU Annex V test methods B.1, B.1 bis, B.1 tris; OCSPP 870.1100; OPPT 798.1175; OPP 81-1)